U.S. Active Pharmaceutical Ingredients CDMO Market Summary The U.S. Active Pharmaceutical Ingredients CDMO Market was valued at USD 25.28 billion in 2024 and is projected to reach USD 33.86 billion by 2030, expanding at a compound annual growth rate (CAGR) of 5.1% from 2025 to 2030. This growth is largely attributed to the increasing need for advanced pharmaceutical manufacturing...